Skip to main content
Log in

Drug makers took big price increases on common US drugs

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The analysis used proprietary data from Truven Health Analytics for the top 10 drugs, identified from IMS Health's 2014 sales figures.

Reference

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug makers took big price increases on common US drugs. PharmacoEcon Outcomes News 751, 2 (2016). https://doi.org/10.1007/s40274-016-2962-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2962-z

Navigation